Good Day Pharmacy UPDATE on COVID-19 Vaccine Information for LTC Residents & Staff

September 24, 2021

Hello Community Partners!

Below is this week’s update around COVID vaccinations. We hope you are doing well and staying safe!

All information is based on CDC, FDA, and CDPHE (State of Colorado) guidance.

UPDATE!

Boosters are approved for some: Yesterday, CDC’s ACIP committee met and voted to approve a 3rd dose “booster” of Pfizer* for certain patients. In an unusual move, the CDC’s leadership overruled the ACIP recommendation and approved the booster for:

  • people 65 years and older and residents in long-term care settings should receive a booster shot of Pfizer’s COVID-19 vaccine at least 6 months after their Pfizer- primary series,
  • people aged 50–64 years with underlying medical conditions should receive a booster shot of Pfizer’s COVID-19 vaccine at least 6 months after their Pfizer primary series,
  • people aged 18–49 years with underlying medical conditions may receive a booster shot of Pfizer’s COVID-19 vaccine at least 6 months after their Pfizer primary series, based on their individual benefits and risks, and
  • people aged 18-64 years who are at increased risk for COVID-19 exposure and transmission because of occupational (healthcare workers/first responders) or institutional setting may receive a booster shot of Pfizer’s COVID-19 vaccine at least 6 months after their Pfizer primary series, based on their individual benefits and risks.

This is ONLY for those who receive PFIZER as their initial vaccine series at least 6 months after their second dose.

*Boosters are authorized for Pfizer recipients only. There is not a recommendation for Moderna or J & J YET.

We know the state has communicated October 11th as the “deadline” for booster doses for categories 1 and 2. This was based on a September 20 start date. There is flexibility to extend this date to October 18th. We are in this together and will do our BEST to coordinate with you!

REMINDERS!

1. We are scheduling FLU CLINICS now! Follow this link to sign up for one of our clinics and have one more task checked off your list!

Vaccination Clinic Interest Form-LTC This link will also gather COVID vaccine info. If you have already completed the form, THANK YOU and you are good to go.

2. Coadministration of COVID vaccine with other vaccines (flu, pneumonia) is fine. There is no need to wait 14 days in between.

Read about this here- https://www.cdc.gov/vaccines/covid-19/clinical-considerations/covid-19-vaccines-us.html#Coadministration This will be advantageous for those partners who also schedule FLU clinics with Good Day.

3. Read more about boosters this here: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.html

4. An additional (third dose) of mRNA vaccine (Pfizer, Moderna) is approved and recommended for Immunocompromised patients. Read about the definition here https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/immuno.html

If you have specific COVID-19 questions, please email us at mobrien@gooddaypharmacy.com and she will get your question to the right person.

Thank you,

Vicki Einhellig, RPh

President & CEO

August 23, 2021

Hello Community Partners,

We have important updates for your teams~

The Pfizer COVID 19 vaccine is FDA APPROVED. The FDA has granted full approval to the Pfizer COVID-19 Vaccine (Brand name- Comirnaty) for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Good Day Pharmacy has both Pfizer and Moderna vaccine for residents and staff.

Booster doses:

The US Department of Health and Human Services has announced plans to offer a booster shot for fully vaccinated people starting September 20. However, we are awaiting formal guidance from Federal and State health agencies on the process for administering booster shots. Once we receive that guidance, we will share information with you about how to schedule booster shots. At this time, additional doses for fully vaccinated people are only available to those who are immunocompromised. If the FDA authorizes and ACIP recommends a booster dose, the goal is for the first people eligible for a booster dose to be the first to receive a COVID-19 vaccination (those who are most at risk). This includes healthcare providers, residents of long-term care facilities, and other older adults.

There are two distinct potential uses for an additional dose of COVID-19 vaccine:

  1. Additional dose after an initial primary vaccine series: an additional dose of vaccine administered when the immune response following a primary vaccine series is likely to be insufficient. An additional mRNA COVID-19 vaccine dose is recommended for moderately to severely immunocompromised people after an initial 2-dose primary mRNA vaccine series.
  2. Booster dose is an additional vaccine administered when the initial sufficient immune response to a primary vaccine series is likely to have waned over time. The need for and timing of a COVID-19 booster dose has not been established. Therefore, no booster doses are recommended at this time. This guidance will be updated as more information becomes available.

For more information about who might be eligible for an additional dose, visit https://www.cdc.gov/coronavirus/2019-ncov/vaccines/booster-shot.htmlthe

Another important update: CMS issued a statement announcing that, in collaboration with the CDC, the agency is developing an emergency regulation that would apply to all nursing homes participating in Medicare and Medicaid that all staff must be vaccinated against COVID-19. It is unclear how CMS expects to audit or enforce this new mandate, which will apply to over 15,000 nursing homes, but the agency expects guidance to be released sometime in September. CMS strongly encourages nursing home staff to get vaccinated ahead of the release of the guidance. Good Day is actively monitoring and will share details as soon as they become available.

More information will be coming soon! If you have specific COVID-19 questions, please email us at mobrien@gooddaypharmacy.com.

Thank you,

Vicki Einhellig, RPh

President & CEO